Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways
Larissa Moutsimilli(Inserm), Eleni T. Tzavara(Inserm), Flavie Mathieu(Inserm), Salah El Mestikawy(Inserm), Sylvie Dumas(Laboratoire de Neurobiologie Cellulaire et Moléculaire), Jean‐Baptiste Sibarita(Centre National de la Recherche Scientifique), Séverine Farley(Centre National de la Recherche Scientifique), Marie‐Anne El Khoury(Centre National de la Recherche Scientifique), Bruno Giros(Centre National de la Recherche Scientifique), Christophe Chamot(Centre National de la Recherche Scientifique), Victor Racine(Centre National de la Recherche Scientifique)
Cited by 35
Related Papers
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
|Brain Research|1991|865
Profound neuronal plasticity in response to inactivation of the dopamine transporter
|Proceedings of the National Academy of Sciences|1998|724